We are live on
!
Find out more
VCNX
Vaccinex, Inc. Common Stock
VCNX
VCNX
Delisted
VCNX was delisted on the 17th of December, 2024.
16 hedge funds and large institutions have $834K invested in Vaccinex, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
33% more funds holding
Funds holding: 12 → 16 (+4)
80% less capital invested
Capital invested by funds: $4.26M → $834K (-$3.42M)
88% less call options, than puts
Call options by funds: $22K | Put options by funds: $187K
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
1
Closed
5
Calls
$22K
Puts
$187K
Net Calls
-$165K
Net Calls Change
-$165K
Top Buyers
| 1 |
TI
Telemetry Investments
New York
|
+$303K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$239K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$237K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$161K |
| 5 |
VF
Virtu Financial
New York
|
+$136K |
Top Sellers
| 1 |
MP
MSD Partners
New York
|
-$3.33M |
| 2 |
Millennium Management
New York
|
-$111K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$61.1K |
| 4 |
Bank of New York Mellon
New York
|
-$57K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
